← Eichor
Study identifier: NCT06998641 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

EFFECTİVİTY OF CHITOSAN COVERED GAUZE IN POSTPARTUM HEMORRHAGIC OBSTETRIC LACERATIONS

Condition: Comparison of the Effect of Chitosan Covered Gauze With Suturing in Terms of Hemostasis in Post-partum Haemorrhagic Tears  ·  Sponsor: Istanbul Training and Research Hospital

PhaseNA
Planned participants62
Who can joinFemale, 18 Years to 48 Years
Healthy volunteersNo

About this study

This study was planned to investigate the efficacy of different treatment methods that can be used in the treatment of hemorrhagic tears that may occur in the postpartum period. The volunteers who will participate in the study will be evaluated during the hospitalization period after delivery and at the end of the puerperium 6 weeks after delivery, in accordance with routine postpartum control examinations. In the treatment of postpartum hemorrhagic tears, the treatment options such as suturing the tears to stop bleeding or applying tampons with bleeding stopping agent (chitosan) and compression effect to the torn area will be determined completely randomly.

This description comes directly from the study's public registry record.

Talk to the study team

Doruk C Katlan  ·  +90 535 347 54 11  ·  dcek2000@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Istanbul Training and Research Hospital Department of Obstetrics and GynecologyIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06998641